Neurocrine Biosciences
NBIX
#1417
Rank
NZ$21.33 B
Marketcap
$210.75
Share price
1.42%
Change (1 day)
15.77%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend history for this company